"The purpose of this document is to provide standard technical information to support Public Health Ontario’s (PHO) Annual Report on Vaccine Safety in Ontario, 2018 and related surveillance products. Technical information includes a brief background on vaccine safety surveillance in Canada, adverse event following immunization (AEFI) surveillance reporting processes in Ontario and an in-depth explanation of analytic methods used in the report,as well as notes on interpretation and limitations of AEFI surveillance data." - Annual Report on Vaccine Safety in Ontario, 2018 - Technical Annex
Annual Report on Vaccine Safety in Ontario, 2018 - Technical Annex
NACI Rapid Response: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccines
Summary of the National Advisory Committee on Immunization (NACI) Statement of November 19, 2021: Recommendation on the use of the PfizerBioNTech COVID-19 vaccine (10 mcg) in children 5-11 years of age
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.